Share Share on Facebook Share on Twitter Pinterest Email Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 Download the PDF here. This post appeared first on investingnews.com 0 admin Website Related Posts Gold Price Breaches US$4,000, Silver Tests US$50 October 9, 2025 How to Invest in Platinum Stocks, Bullion and More October 9, 2025 BHP to Invest Over AU$840 Million in Olympic Dam Operation as Copper Demand Grows October 9, 2025